According to the FDA, they have not received official approval, and no comprehensive safety data has been submitted for them.

Daily Mail journalists select and curate the products that feature on our site. If you make a purchase via links on this page we will earn commission - learn more Hair loss is, for many, an ...

Hims & Hers Health (HIMS) stock declined about 2% yesterday. The fall came after the U.S. Food and Drug Administration (FDA) ...

A quick spray of medication might seem like an easy way to get thicker hair, but some folks say one sold online has left them ...

These hair aid products, which are in spray and serum formats, are not approved by the FDA but they are available via a ...

The Food and Drug Administration on Tuesday posted a warning about generic forms of a popular hair-loss medication often sold by major telehealth companies including Hims, Keeps and Ro, citing reports ...

While the pill form of finasteride, known by the brand name Propecia, is FDA-approved to treat hair loss ... after using finasteride prescriptions purchased from the telehealth companies Hims ...

Oral finasteride is an FDA-approved medication designed to help prevent hair loss. It specifically blocks type‑II ...

The FDA’s alert does not prevent Hims Hers Health from continuing to sell the treatment, but it raises questions about the future of these products in the market. The agency has stressed that ...

Hims & Hers stock has dropped over 60% from its peak due to concerns about its GLP-1 business. Read why I think HIMS stock is ...